Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases-Reference-Cited by-同舟云学术

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

Published:2010-09 Issue:3 Volume:252 Page:426-433
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Giuliano Armando E.,McCall Linda,Beitsch Peter,Whitworth Pat W.,Blumencranz Peter,Leitch A. Marilyn,Saha Sukamal,Hunt Kelly K.,Morrow Monica,Ballman Karla

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference23 articles.

1. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.;Giuliano;J Clin Oncol,2000

2. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study.;Bergkvist;Ann Surg,2008

3. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.;Veronesi;N Engl J Med,2003

4. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.;Lyman;J Clin Oncol,2005

5. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania.;Schwartz;Cancer,2002

Cited by 1007 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer-related lymphedema: A critical review on recent progress;Surgical Oncology;2024-10

2. Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy;Annals of Surgical Oncology;2024-09-04

3. Omitting Axillary Lymph Node Dissection Is Associated With an Increased Risk of Regional Recurrence in Early Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials;Clinical Breast Cancer;2024-08

4. Should Palpable Nodes Be Exclusionary in Patients Who Are Otherwise Candidates for ACOSOG Z0011-Type Trials?;Annals of Surgical Oncology;2024-07-16

5. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial;Annals of Surgical Oncology;2024-07-12